149 related articles for article (PubMed ID: 17921818)
41. NO/PGI2-independent vasorelaxation and the cytochrome P450 pathway in rabbit carotid artery.
Dong H; Waldron GJ; Galipeau D; Cole WC; Triggle CR
Br J Pharmacol; 1997 Feb; 120(4):695-701. PubMed ID: 9051310
[TBL] [Abstract][Full Text] [Related]
42. Vasorelaxing effect of U50,488H in pulmonary artery and underlying mechanism in rats.
Sun X; Ma S; Zang YM; Lu SY; Guo HT; Bi H; Wang YM; Ma H; Ma XL; Pei JM
Life Sci; 2006 Apr; 78(21):2516-22. PubMed ID: 16336977
[TBL] [Abstract][Full Text] [Related]
43. The quest for endothelial atypical cannabinoid receptor: BK
Bondarenko AI; Panasiuk O; Drachuk K; Montecucco F; Brandt KJ; Mach F
Vascul Pharmacol; 2018 Mar; 102():44-55. PubMed ID: 29355732
[TBL] [Abstract][Full Text] [Related]
44. The endogenous cannabinoid anandamide inhibits cromakalim-activated K+ currents in follicle-enclosed Xenopus oocytes.
Oz M; Yang KH; Dinc M; Shippenberg TS
J Pharmacol Exp Ther; 2007 Nov; 323(2):547-54. PubMed ID: 17682128
[TBL] [Abstract][Full Text] [Related]
45. Endothelium-dependent relaxation is resistant to inhibition of nitric oxide synthesis, but sensitive to blockade of calcium-activated potassium channels in essential hypertension.
Sainsbury CA; Coleman J; Brady AJ; Connell JM; Hillier C; Petrie JR
J Hum Hypertens; 2007 Oct; 21(10):808-14. PubMed ID: 17508013
[TBL] [Abstract][Full Text] [Related]
46. Endothelium-dependent vasorelaxation independent of nitric oxide and K(+) release in isolated renal arteries of rats.
Jiang F; Dusting GJ
Br J Pharmacol; 2001 Apr; 132(7):1558-64. PubMed ID: 11264250
[TBL] [Abstract][Full Text] [Related]
47. Relaxation to bradykinin in bovine pulmonary supernumerary arteries can be mediated by both a nitric oxide-dependent and -independent mechanism.
Tracey A; Bunton D; Irvine J; MacDonald A; Shaw AM
Br J Pharmacol; 2002 Oct; 137(4):538-44. PubMed ID: 12359636
[TBL] [Abstract][Full Text] [Related]
48. Characterization of endothelium-derived relaxing factors released by bradykinin in human resistance arteries.
Ohlmann P; Martínez MC; Schneider F; Stoclet JC; Andriantsitohaina R
Br J Pharmacol; 1997 Jun; 121(4):657-64. PubMed ID: 9208131
[TBL] [Abstract][Full Text] [Related]
49. A cannabinoid receptor, sensitive to O-1918, is involved in the delayed hypotension induced by anandamide in anaesthetized rats.
Zakrzeska A; Schlicker E; Baranowska M; Kozłowska H; Kwolek G; Malinowska B
Br J Pharmacol; 2010 Jun; 160(3):574-84. PubMed ID: 20105178
[TBL] [Abstract][Full Text] [Related]
50. A role for N-arachidonylethanolamine (anandamide) as the mediator of sensory nerve-dependent Ca2+-induced relaxation.
Ishioka N; Bukoski RD
J Pharmacol Exp Ther; 1999 Apr; 289(1):245-50. PubMed ID: 10087011
[TBL] [Abstract][Full Text] [Related]
51. Differential mechanisms for insulin-induced relaxations in mouse posterior tibial arteries and main mesenteric arteries.
Qu D; Liu J; Lau CW; Huang Y
Vascul Pharmacol; 2014 Dec; 63(3):173-7. PubMed ID: 25446161
[TBL] [Abstract][Full Text] [Related]
52. Relaxation of human pulmonary arteries by PPARγ agonists.
Kozłowska H; Baranowska-Kuczko M; Schlicker E; Kozłowski M; Kloza M; Malinowska B
Naunyn Schmiedebergs Arch Pharmacol; 2013 May; 386(5):445-53. PubMed ID: 23483194
[TBL] [Abstract][Full Text] [Related]
53. Vasodilatory effects of cannabidiol in human pulmonary and rat small mesenteric arteries: modification by hypertension and the potential pharmacological opportunities.
Baranowska-Kuczko M; Kozłowska H; Kloza M; Sadowska O; Kozłowski M; Kusaczuk M; Kasacka I; Malinowska B
J Hypertens; 2020 May; 38(5):896-911. PubMed ID: 31800399
[TBL] [Abstract][Full Text] [Related]
54. Inhibitory effects of endocannabinoid on the action potential of pacemaker cells in sinoatrial nodes of rabbits.
Zhang J; Wang SY; Zhou JJ; Wei Y; Li Q; Yang J; Zhang Y
Sheng Li Xue Bao; 2013 Apr; 65(2):129-34. PubMed ID: 23598867
[TBL] [Abstract][Full Text] [Related]
55. Role of Endothelium in Abnormal Cannabidiol-Induced Vasoactivity in Retinal Arterioles.
Su EN; Kelly ME; Cringle SJ; Yu DY
Invest Ophthalmol Vis Sci; 2015 Jun; 56(6):4029-37. PubMed ID: 26098470
[TBL] [Abstract][Full Text] [Related]
56. Mechanisms of vasorelaxation induced by the cannabidiol analogue compound O-1602 in the rat small mesenteric artery.
Al Suleimani YM; Al Mahruqi AS; Hiley CR
Eur J Pharmacol; 2015 Oct; 765():107-14. PubMed ID: 26297305
[TBL] [Abstract][Full Text] [Related]
57. The novel endocannabinoid receptor GPR55 is activated by atypical cannabinoids but does not mediate their vasodilator effects.
Johns DG; Behm DJ; Walker DJ; Ao Z; Shapland EM; Daniels DA; Riddick M; Dowell S; Staton PC; Green P; Shabon U; Bao W; Aiyar N; Yue TL; Brown AJ; Morrison AD; Douglas SA
Br J Pharmacol; 2007 Nov; 152(5):825-31. PubMed ID: 17704827
[TBL] [Abstract][Full Text] [Related]
58. Functional evidence of a role for two-pore domain potassium channels in rat mesenteric and pulmonary arteries.
Gardener MJ; Johnson IT; Burnham MP; Edwards G; Heagerty AM; Weston AH
Br J Pharmacol; 2004 May; 142(1):192-202. PubMed ID: 15066906
[TBL] [Abstract][Full Text] [Related]
59. Cannabinoids alter endothelial function in the Zucker rat model of type 2 diabetes.
Stanley CP; Wheal AJ; Randall MD; O'Sullivan SE
Eur J Pharmacol; 2013 Nov; 720(1-3):376-82. PubMed ID: 24120371
[TBL] [Abstract][Full Text] [Related]
60. Mechanism of thrombin-induced vasodilation in human coronary arterioles.
Bosnjak JJ; Terata K; Miura H; Sato A; Nicolosi AC; McDonald M; Manthei SA; Saito T; Hatoum OA; Gutterman DD
Am J Physiol Heart Circ Physiol; 2003 Apr; 284(4):H1080-6. PubMed ID: 12595282
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
